Cure4Lupus.org
For Lupus Fighters, By Lupus Fighters.
Promoting Lupus
Awareness and
Research to Find a Cure.
Providing
Information,
Support, &
Lupus Awareness Products.
Place an order online or by phone 402-201-9945, 9am to Midnight
Treatments ResearchThere are many Lupus treatment research projects currently being conducted. Below are links to more information about many of them. MedImmune - Medi-545 is an antibody that targets Interferon-alpha. It has been in Phase 2A trials since Aug. 2008. more... Genentech - Rontalizumab, an antibody targeting Interferon-alpha is in Phase II trials. Immunomedics, Inc. - Epratuzamab an anti-CD22 antibody announced positive data in a Phase IIb study. Phase III testing planned. more... Human Genome Science - Belimumab (Benlysta) is an anti-BLyS medication has met it's primary endpoint in two pivotal Phase 3 trials. In the final Phase III trial (76 week), Benlysta failed to show more effective than placebo. FDA approval will still be pursued. more... ImmuPharma - Lupuzor has successfully completed phase I, Phase IIa and Phase IIb studies and is now in preparation for phase III. has a novel mechanism of action aimed at modulating the body’s immune system so it does not attack healthy cells without causing adverse side effects. It has the potential to halt the progression of the disease in a substantial proportion of patients. In May 2010 it was announced that Phase III testing to begin within weeks. more... Merck Serono - Atacicept (TACI-Ig) in 2 Phase II/III trials. Atacicept is an anti-BLyS, anti-APRIL protein. La Jolla Pharmaceuticals - Abetimus sodium, LJP 394, Rentol, Riquent is an anti B cell therapy in ongoing Phase III trials. Trubion Pharmaceuticals/Wyeth - Phase I clinical trial of SBI-087 for SLE was started in March of '09, SBI-087 targets CD-20 more info... Neovacs - Begining Phase I/II trials w/ their Interferon alpha (IFN?) Kinoid in lupus patients. TNF?-K, IFN?-K and VEGF-K are the candidates. more info... Amgen - Anti-interferon gamma antibody, AMG811 started a Phase Ib trial in Mar. 2009. more... Amgen - AMG557 is an anti-T cell antibody. AMG557 is currently in Phase I trials. more... Active Biotech - Paquinimod (ABR-215757) is an oral compound used to regulate the immune system in SLE. It completed a Phase Ib trial and is conducting Phase II/III trials. more... Stem Cell Transplants - There are currently several studies being conducted on stem cell transplants in Lupus. One by Nanjing Medical University in China, one by Duke University in North Carolina, another is being conducted at Stanford University in California, there is one in Germany, and another at Northwestern University in Chicago. Fred Hutchinson Cancer Research Center in Washington D.C. has also initiated a study on this procedure in children. Anthera Pharmaceuticals Inc. - A-623 is an inhibitor to B-Cell Activating Factor (BAFF). In July of 2010 a Phase IIb study was initiated. more... See also: Clinical Trials, SLE Genetic Studies, Government Research & Online Lupus Studies |
News Question of the month:
Advertisers |
9417 Park Drive #201, Omaha, NE 68127
Webmaster@Cure4Lupus.org 402-201-9945
Text on this page may be copied and reposted if there is a link to this site posted with it.
This is not a medical website and information on this site should never be substituted for medical advice. Always consult a physician before making any medical decisions!
Cure4Lupus.org is a philanthropic organization. It is not a 501(c)3 non-profit organization. It donates most profits to 501(c)3 organizations, however it is a for profit business independent of the Lupus Foundation of America or any other organization.